Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model

Journal of Clinical Investigation

Volumn 105, Issue 2, 2000, Pages 173-181

  Huang, Christene A ^a   Fuchimoto, Yasushi ^a   Scheier Dolberg, Rachel ^a   Murphy, Michael C ^a   Neville Jr , David M ^b   Sachs, David H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; CYTOKINE; IMMUNOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SKIN GRAFT; SWINE; THYMUS; WHOLE BODY RADIATION;

EID: 0033966351     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7913     Document Type: Article

References (39)

1. Ildstad, S.T., and Sachs, D.H. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 307:168-170.
2. Sykes, M., and Sachs, D.H. 1988. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol. Today. 9:23-27.
3. Sharabi, Y., and Sachs, D.H. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med. 169:493-502.
4. Tomita, Y., Sachs, D.H., Khan, A., and Sykes, M. 1996. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation. 61:469-477.
5. Colson, Y.L., et al. 1996. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J. Immunol. 157:2820-2829.
6. Stewart, F.M., et al. 1998. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood. 91:3681-3687.
7. Singer, A., Hathcock, K.S., and Hodes, R.J. 1981. Self recognition in allogeneic radiation bone marrow chimeras. J. Exp. Med. 153:1286-1301.
8. Ildstad, S.T., Wren, S.M., Bluestone, J.A., Barbieri, S.A., and Sachs, D.H. 1985. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162:231-244.
9. Sykes, M., Sheard, M.A., and Sachs, D.H. 1988. Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells. J. Exp. Med. 168:2391-2396.
10. Sykes, M., Eisenthal, A., and Sachs, D.H. 1988. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component. J. Immunol. 140:2903-2911.
11. Ildstad, S.T., et al. 1986. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-hosr disease in mixed allogeneic chimeras (B10 + B10.D2 -B10). J. Immunol. 136:28-33.
12. Sakamoto, K., et al. 1988. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow. Transplantation. 45:869-875.
13. Popitz-Bergez, F.A., et al. 1988. Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival. Transplantation. 45:27-31.
14. Pennington, L.R., et al. 1988. Bone marrow transplantation in miniature swine. I. Development of the model. Transplantation. 45:21-26.
15. Smith, C.V., et al. 1993. Bone marrow transplantation in miniature swine. IV. Development of myeloablative regimens that allow engraftment across major histocompatibility barriers. Transplantation. 56:541-549.
16. Huang, C.A., et al. 1999. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation. 68:855-860.
17. Sachs, D.H., et al. 1976. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation. 22:559-567.
18. Pennington, L.R., Lunney, J.K., and Sachs, D.H. 1981. Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation. 31:66-71.
19. Pescovitz, M.D., Lunney, J.K., and Sachs, D.H. 1984. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J. Immunol. 133:368-375.
20. Huang, C.A., et al. 1999. Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation. 5:201-212.
21. Saalmuller, A., et al. 1996. The Second International Swine CD Workshop. Vet. Immunol. Immunopathol. 54:155-158.
22. Pescovitz, M.D., Lunney, J.K., and Sachs, D.H. 1984. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J. Immunol. 133:368-375.
23. Fuchimoto, Y., et al. 1999. An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs. Tissue Antigens. 54:43-52.
24. Leight, G.S., et al. 1978. Transplantation in miniature swine. III. Effects of MSLA and A-O blood group matching on skin allograft survival. Tissue Antigens. 12:65-74.
25. Cobbold, S.P., Martin, G., Qin, S., and Waldmann, H. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature. 323:164-166.
26. Sykes, M., and Sachs, D.H. 1988. Mixed allogeneic chimerism as an approach to transplantation tolerance [erratum 1988, 9:131]. Immunol. Today. 9:23-27.
27. Kawai, T., Wong, J., MacLean ,J., Cosimi, A.B., and Wee, S.L. 1994. Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant. Proc. 26:1845-1846.
28. Suzuki, T., Sundt, T.M., Mixon, A., and Sachs, D.H. 1990. In vivo treatment with anti-porcine T-cell antibodies. Transplantation. 50:76-81.
29. Neville, D.M.J., et al. 1996. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J. Immunother. Emphasis Tumor Immunol. 19:85-92.
30. Knechtle, S.J., et al. 1997. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation. 63:1-6.
31. Contreras, J.L., et al. 1998. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation. 65:1159-1169.
32. Knechtle, S.J., et al. 1998. Primate renal transplants using immunotoxin. Surgery. 124:438-446.
33. Yu, C., et al. 1995. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. Blood. 86:4376-4381.
34. Storb, R., et al. 1997. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood. 89:3048-3054.
35. Boyse, E.A., et al. 1970. Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature. 227:901-903.
36. Boyse, E.A., Carswell, E.A., Scheid, M.P., and Old, L.J. 1973. Tolerance of Sk-incompatible skin grafts. Nature. 244:441-442.
37. Steinmuller, D., and Lofgreen, J.S. 1974. Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature. 248:796-797.
38. Darby, S.C., Nakashima, E., and Kato, H. 1985. A parallel analysis of cancer mortality among atom bomb survivors and patients with ankylosing spondylitis. J. Natl. Cancer Inst. 75:1-21.
39. Darby, S.C., Doll, R., Gill, S.K., and Smith, P.C. 1987 Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer. 55:179-190.